Registry for Bone Metastases

The International Bone Metastasis Registry

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07391410

Enrollment

500

Registered

2026-02-05

Start date

2026-01-13

Completion date

2031-01-01

Last updated

2026-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Metastases

Keywords

23-175

Brief summary

The purpose of this study is to learn more about symptomatic bone metastases. This study is an international patient registry of people with symptomatic bone metastases. A patient registry is a database - a collection of health information - about a group of people, and it is usually focused on a specific diagnosis or condition.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

22 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age ≥22 years * Biopsy-proven or clinically obvious metastatic bone disease . For purposes of this study, metastatic bone disease includes skeletal involvement from multiple myeloma. * Symptomatic bone lesion requiring intervention * This includes but is not limited to radiotherapy, cryotherapy, radiofrequency ablation, operative fixation, prosthetic replacement, amputation, or any combination of the above

Exclusion criteria

* Age \<22 years

Design outcomes

Primary

Measure	Time frame
overall survival	10 years

Countries

United States

Contacts

CONTACTJonathan Forsberg, MD, PhD

forsbej@mskcc.org212-639-2076

CONTACTCarol Morris, MD

212-639-7611

PRINCIPAL_INVESTIGATORJonathan Forsberg, MD, PhD

Memorial Sloan Kettering Cancer Center

Outcome results